AKTX
Akari Therapeutics
AKTX
AKTX
12 hedge funds and large institutions have $2.93M invested in Akari Therapeutics in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$357K | |
| 2 | +$18K | |
| 3 | +$4.16K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.77K |
Top Sellers
| 1 | -$88K | |
| 2 | -$55K | |
| 3 | -$18K | |
| 4 |
Renaissance Technologies
New York
|
-$1.39K |